These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 9044310

  • 1. Administration of AGEs in vivo induces extracellular matrix gene expression.
    Striker LJ, Striker GE.
    Nephrol Dial Transplant; 1996; 11 Suppl 5():62-5. PubMed ID: 9044310
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease.
    Yang CW, Vlassara H, Peten EP, He CJ, Striker GE, Striker LJ.
    Proc Natl Acad Sci U S A; 1994 Sep 27; 91(20):9436-40. PubMed ID: 7937785
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Overexpression of transforming growth factor-beta 1 mRNA is associated with up-regulation of glomerular tenascin and laminin gene expression in nonobese diabetic mice.
    Yang CW, Hattori M, Vlassara H, He CJ, Carome MA, Yamato E, Elliot S, Striker GE, Striker LJ.
    J Am Soc Nephrol; 1995 Feb 27; 5(8):1610-7. PubMed ID: 7538809
    [Abstract] [Full Text] [Related]

  • 6. Chrysin Inhibits Advanced Glycation End Products-Induced Kidney Fibrosis in Renal Mesangial Cells and Diabetic Kidneys.
    Lee EJ, Kang MK, Kim DY, Kim YH, Oh H, Kang YH.
    Nutrients; 2018 Jul 09; 10(7):. PubMed ID: 29987200
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Roles of advanced glycation end-products in the progression of diabetic nephropathy.
    Makino H, Shikata K, Kushiro M, Hironaka K, Yamasaki Y, Sugimoto H, Ota Z, Araki N, Horiuchi S.
    Nephrol Dial Transplant; 1996 Jul 09; 11 Suppl 5():76-80. PubMed ID: 9044313
    [Abstract] [Full Text] [Related]

  • 9. Localization of glycated proteins in the glomeruli of patients with diabetic nephropathy.
    Sakai H, Jinde K, Suzuki D, Yagame M, Nomoto Y.
    Nephrol Dial Transplant; 1996 Jul 09; 11 Suppl 5():66-71. PubMed ID: 9044311
    [Abstract] [Full Text] [Related]

  • 10. Extracellular matrix is modulated in advanced glycation end products milieu via a RAGE receptor dependent pathway boosted by transforming growth factor-β1 RAGE.
    Serban AI, Stanca L, Geicu OI, Munteanu MC, Costache M, Dinischiotu A.
    J Diabetes; 2015 Jan 09; 7(1):114-24. PubMed ID: 24666836
    [Abstract] [Full Text] [Related]

  • 11. Glomerular expression of platelet-derived growth factor (PDGF)-A, -B chain and PDGF receptor-alpha, -beta in human diabetic nephropathy.
    Uehara G, Suzuki D, Toyoda M, Umezono T, Sakai H.
    Clin Exp Nephrol; 2004 Mar 09; 8(1):36-42. PubMed ID: 15067514
    [Abstract] [Full Text] [Related]

  • 12. Advanced glycation end products modulate transcriptional regulation in mesangial cells.
    Iehara N, Takeoka H, Yamada Y, Kita T, Doi T.
    Kidney Int; 1996 Oct 09; 50(4):1166-72. PubMed ID: 8887274
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of Advanced Glycation End Products (AGEs) Accumulation by Pyridoxamine Modulates Glomerular and Mesangial Cell Estrogen Receptor α Expression in Aged Female Mice.
    Pereira-Simon S, Rubio GA, Xia X, Cai W, Choi R, Striker GE, Elliot SJ.
    PLoS One; 2016 Oct 09; 11(7):e0159666. PubMed ID: 27428057
    [Abstract] [Full Text] [Related]

  • 14. Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy.
    Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA.
    Proc Natl Acad Sci U S A; 1993 Mar 01; 90(5):1814-8. PubMed ID: 7680480
    [Abstract] [Full Text] [Related]

  • 15. Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195.
    Tsuchida K, Makita Z, Yamagishi S, Atsumi T, Miyoshi H, Obara S, Ishida M, Ishikawa S, Yasumura K, Koike T.
    Diabetologia; 1999 May 01; 42(5):579-88. PubMed ID: 10333051
    [Abstract] [Full Text] [Related]

  • 16. Diabetic nephropathy: molecular analysis of extracellular matrix and clinical studies update.
    Striker GE, Eastman RD, Striker LJ.
    Nephrol Dial Transplant; 1996 May 01; 11 Suppl 5():58-61. PubMed ID: 9044309
    [Abstract] [Full Text] [Related]

  • 17. Differential expression of glomerular extracellular matrix and growth factor mRNA in rapid and slowly progressive glomerulosclerosis: studies in mice transgenic for native or mutated growth hormone.
    Yang CW, Striker GE, Chen WY, Kopchick JJ, Striker LJ.
    Lab Invest; 1997 Apr 01; 76(4):467-76. PubMed ID: 9111509
    [Abstract] [Full Text] [Related]

  • 18. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
    Hou B, Qiang G, Zhao Y, Yang X, Chen X, Yan Y, Wang X, Liu C, Zhang L, Du G.
    Cell Physiol Biochem; 2017 Apr 01; 44(6):2378-2394. PubMed ID: 29262395
    [Abstract] [Full Text] [Related]

  • 19. Advanced glycation end products decrease mesangial cell MMP-7: a role in matrix accumulation in diabetic nephropathy?
    McLennan SV, Kelly DJ, Schache M, Waltham M, Dy V, Langham RG, Yue DK, Gilbert RE.
    Kidney Int; 2007 Aug 01; 72(4):481-8. PubMed ID: 17554258
    [Abstract] [Full Text] [Related]

  • 20. Vascular hypertrophy in experimental diabetes. Role of advanced glycation end products.
    Rumble JR, Cooper ME, Soulis T, Cox A, Wu L, Youssef S, Jasik M, Jerums G, Gilbert RE.
    J Clin Invest; 1997 Mar 01; 99(5):1016-27. PubMed ID: 9062360
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.